After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

A research team from Virginia Commonwealth University has found that a drug currently in clinical trials for brain disorders ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

Have you or someone you love been diagnosed with Alzheimer’s disease? This clinical trial may be just what you.

A team of researchers at the Sant Pau Research Institute (IR Sant Pau) has demonstrated that the plasma biomarker p-tau217, ...

The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope. “Alzheimer’s disease is a specific condition resulting from an abnormal biological ...

A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for ...

The annual review of clinical trials for Alzheimer’s highlights a growing number of active trials and drugs that could help ...

Help Black families facing dementia. Join SHARE, a clinical trial for support, health, activities, resources, and education.

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...